ABPI Leaflet On Drug Risks And Benefits

11 August 1997

Information about the benefits of medicines and their risks - and how tobalance the two - is provided in a new leaflet, prepared by the Association of the British Pharmaceutical Industry and the Long-Term Medical Conditions Alliance. The leaflets will be available, free, to patients, mostly through general practitioners' surgeries.

"While medicines provide protection, cures and alleviation against so many diseases, side effects always have to be taken into account," says ABPI director general Trevor Jones, who adds that "the vast majority are more of a nuisance than a risk, but some can be serious and it's important that patients understand exactly where they are in relation to their treatment." The aim of this leaflet, notes Dr Jones, is to provide basic guidance.

The leaflet, Balancing Risks and Benefits, can also be obtained from the ABPI's publication Department at 12 Whitehall, London SW1A 2DY, UK.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight